Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/21/2003WO2002097127A3 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease
08/21/2003WO2002097123A3 Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels
08/21/2003WO2002095030A3 Modulation of cd200 receptors
08/21/2003WO2002082075A3 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
08/21/2003WO2002079504A3 Neotic and endoapoptotic cells and detection of neosis and endoapoptosis
08/21/2003WO2002074810A3 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
08/21/2003WO2002073214A3 Novel reagents for detecting cannabinoids
08/21/2003WO2002072140A3 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro
08/21/2003WO2002068473A8 Biosensor for detecting chemical agents
08/21/2003WO2002066045A3 Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002059617A3 Standard diluent for multiplex assays
08/21/2003WO2002058623A3 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
08/21/2003WO2002057797A3 Vitamin d assay
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002056749A3 Diagnostic and monitoring methods for cancer
08/21/2003WO2002056022A3 Diagnostics, drug screening and treatment for cancer
08/21/2003WO2002055008A3 Meter strip dispenser assembly
08/21/2003WO2002050545A3 Compositions and methods involving staphylococcus aureus protein staau-r9
08/21/2003WO2002050536A3 Replication assay for detecting anti-viral substances
08/21/2003WO2002050246A3 Treatment of bone disorders by modulation of fgfr3
08/21/2003WO2002048405A3 Non-invasive method for detecting target rna
08/21/2003WO2002047613A3 Immunogenic cancer peptides and uses thereof
08/21/2003WO2002046765A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
08/21/2003WO2002046224A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002044418A3 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002043773A3 Tissue specific prodrugs
08/21/2003WO2002040535A3 Compositions and methods relating to ovary specific genes and proteins
08/21/2003WO2002036615A3 Methods for producing and improving therapeutic potency of binding polypeptides
08/21/2003WO2002035240A3 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
08/21/2003WO2002033638A3 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
08/21/2003WO2002024959A3 Multiple reporter read-out for bioassays
08/21/2003WO2002022890A3 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
08/21/2003WO2002022882A3 Target activated nucleic acid biosensor and methods of using same
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002010433A3 Method and device for detecting bacterial contamination
08/21/2003WO2002010392A9 Mammalian dna binding membrane-associated protein-encoding gene and uses
08/21/2003WO2002000112A3 Glucose metering system
08/21/2003WO2001097794A3 Inhibitors of matriptase for the treatment of cancer
08/21/2003WO2001095230A3 Method for predicting therapeutic agent resistance using neural networks
08/21/2003WO2001094941A3 Diagnostic methods for pompe disease and other glycogen storage diseases
08/21/2003WO2001094641A3 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
08/21/2003WO2001094630A3 Compositions and methods for array-based nucleic acid hybridization
08/21/2003WO2001092581A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
08/21/2003WO2001081929A3 Method and apparatus for predicting a signal peptide cleavage site
08/21/2003WO2001081916A3 Methods of evaluating transplant rejection
08/21/2003WO2001079479A3 Methods for selective targeting
08/21/2003WO2001077365A3 Antimicrobial methods and materials
08/21/2003WO2001059149A3 Peptide biosensors for anthrax protease
08/21/2003US20030159162 Methods of using transporter-like molecules to treat pain and pain-related disorders
08/21/2003US20030158671 Systems and methods for predicting active site residues in a protein
08/21/2003US20030158602 Contacting a cell containing a NELL-1 gene with a test agent; and detecting a change in the expression level of Nell-1 gene as compared to the expression of the NELL-1 gene in a cell that is not contacted with test agent
08/21/2003US20030158499 Automated plunger-based sample/buffer mixing assembly
08/21/2003US20030158472 Methods for monitoring analyte concentration using minimally invasive devices
08/21/2003US20030158407 A Fluorescent dyes for labelling biopolymers and cell surface, a conjugated with polynucleotides or nucleotides
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158388 MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
08/21/2003US20030158385 Novel fungal lipase
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158376 Relaxin-like factor and methods and uses thereof
08/21/2003US20030158262 Ameliorating progression of amyotrophic lateral sclerosis
08/21/2003US20030158211 Methods and compositions for treatment of central nervous system disorders
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158149 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold
08/21/2003US20030158135 Derived from staphylococcal genes; use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or streptogramin B and related compounds in biological sample
08/21/2003US20030158115 Prevents adhesion of specific crystals to the surface of kidney cells and is used in an assay system to rapidly measure relative amounts of crystal adhesion to cells
08/21/2003US20030158109 As markers for distinguishing between tumors which will or have metastasized and those which are less likely to metastasize
08/21/2003US20030158105 Determining polypeptide sequence of at least one Bcr-Abl polypeptide expressed by the human cancer cell and comparing the polypeptide sequence of the Bcr-Abl polypeptide expressed by the human cancer cell to the Bcr-Abl polypeptide sequence
08/21/2003US20030158104 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158085 For diagnosis and therapy of pancreatic disorders, particularly type I diabetes
08/21/2003US20030157732 Capillary electrophoresis; gold complex; quantitative analysis
08/21/2003US20030157731 Analyte assay using particulate labels
08/21/2003US20030157730 Competitive binding patterns
08/21/2003US20030157729 Absorption zone; immobilization sampling; quantitative analysis
08/21/2003US20030157727 Measuring method using long life fluorescence of excitation type
08/21/2003US20030157724 Photometric apparatus using light guide layers/films for analytical investigation of fluid samples from humans or animals
08/21/2003US20030157723 Self-customizing analyte testing system for detection of drugs, ethanol and toxic substances in saliva; immunoassays
08/21/2003US20030157722 Providing a polymer blend matrix; initiating degradation of polymer blend matrix; subjecting degraded polymer blend matrix to high mass and low mass Time- of-Flight Secondary Ion Mass Spectrometry (ToF SIMS) identifying and quantifying oligomers
08/21/2003US20030157719 Reagentless method for determining the concentration of one or more analytes in blood, synovial fluid, semen, feces and cerebrospinal fluid via spectrophotometry; hemolysis
08/21/2003US20030157718 Expression of heterologous genes from an IRES translational cassette in retroviral vectors
08/21/2003US20030157704 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
08/21/2003US20030157699 Solid phase test apparatus/bioassay comprising internal indicator and external marking for detection of antibodies, antigens, drugs, or hormones
08/21/2003US20030157695 Marine actinomycete taxon for drug and fermentation product discovery
08/21/2003US20030157684 Microbial B-glucuronidase genes, gene production and uses thereof
08/21/2003US20030157660 Non-M, non-O HIV-1 strains, fragments and uses
08/21/2003US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003US20030157647 Comprises calcium/glutamate receptor chimera comprising extracellular domain of G-protein coupled membrane protein for treating nervous system disorders
08/21/2003US20030157633 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
08/21/2003US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157628 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 ... 3937